Determination of stage specific markers for liver fibrosis in hepatitis B: A comparative tissue proteomic study
View/ Open
Access
info:eu-repo/semantics/openAccessDate
2016Author
Katrinli, ŞeymaÖzdil, Kamil
Şahin, Aslı
Öztürk, Oğuzhan
Kır, Gözde
Baykal, Ahmet Tarık
Saraç, Ömer Sinan
Sökmen, Mehmet
Dinler Doğanay, Gizem
Doğanay, Hamdi Levent
Metadata
Show full item recordCitation
Katrinli, Ş., Özdil, K., Şahin, A., Öztürk, O., Kır, G., Baykal, A. T. ... Doğanay, H. L. (2016). Determination of stage specific markers for liver fibrosis in hepatitis B: A comparative tissue proteomic study. EASL International Liver Congress içinde (S446-S446. ss.). Barcelona, Spain, April 13-17, 2016. https://dx.doi.org/10.1016/S0168-8278(16)00738-8Abstract
Background and Aims: Chronic Hepatitis B infection is one of themajor causes of liver cirrhosis and around 600,000 people dieannually worldwide. The virus itself is non-cytopathic and the liverdamage is due to host immune reaction. Thus liver damage pathwaysmight differ in chronic HBV and comprehensive tissue proteomicanalysis is missing in literature. To estimate which patient withchronic hepatitis B will develop rapidly fibrosis or cirrhosis is yet athorny issue and requires a vast recognition of cellular pathwaysinvolved in fibrosis. The aim of this study is to enlighten pathwaysassociated with liver fibrosis in HBV infection for leading up to newtherapeutic targets and diagnostic biomarkers.
WoS Q Kategorisi
Q1Source
EASL International Liver CongressVolume
64Issue
Supplement: 2Collections
- Bildiri Koleksiyonu [515]
- WoS İndeksli Yayınlar Koleksiyonu [6546]